Ajanta Pharma Ltd.
NSE: AJANTPHARM | BSE: 532331
₹3,248.20
₹34.10
(1.06%)
As on 19-May-2026IST
Market cap
₹40,762 Cr
Revenue (TTM)
₹5,453 Cr
P/E Ratio
38.6
P/B Ratio
9
Div. Yield
0.9 %
Quality Score
9/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1,056 Cr
-
ROE
25.1 %
-
ROCE
32.9 %
-
Industry P/E
33.65
-
EV/EBITDA
26.1
-
Debt to Equity
0
-
Book Value
₹362.3
-
EPS
₹84.5
-
Face value
2
-
Shares outstanding
124,935,624
10 Years Aggregate
CFO
₹5,920.26 Cr
EBITDA
₹8,324.62 Cr
Net Profit
₹5,936.84 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ajanta Pharma
| 17.3 | 16.4 | 9.7 | 24.8 | 36.7 | 20.6 | 11.9 |
|
BSE Healthcare
| 9.5 | 9.4 | 9.8 | 12.1 | 27.6 | 14.5 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Ajanta Pharma
| -7.5 | 35.8 | 71.9 | -18.7 | 35.4 | 66.9 | -17.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ajanta Pharma
|
3,248.2 | 40,761.5 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38.6 | 9.0 |
| 557.4 | 1,601.4 | 502.6 | 57.9 | 13.8 | 18.2 | 27.6 | 4.3 | |
| 282.8 | 2,976.9 | 927.1 | 134.7 | 12.8 | 11.2 | 23.1 | 2.5 | |
| 2,038.2 | 15,504.9 | 2,187.2 | 649.7 | 31.5 | 19 | 24.2 | 4.3 | |
| 197.2 | 1,327.0 | 287.2 | 43.1 | 16.9 | 16.9 | 30.8 | 4.8 | |
| 2,171.6 | 34,915.1 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.2 | 8.4 | |
| 4,785.4 | 21,873.6 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.3 | 5.2 | |
| 766.8 | 1,706.1 | 251.7 | 30.5 | 18.0 | 9.7 | 56 | 5.3 | |
| 3,230.9 | 7,426.0 | 1,773.8 | 309.8 | 24.0 | 43.1 | 24 | 9.5 | |
| 1,153.6 | 10,633.5 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Research Desk
2 min read•By Value Research
Is your company's RoCE rising every year?
1 min read•By Vikas Vardhan
2 min read•By Mohammed Ekramul Haque
2 min read•By Mohammed Ekramul Haque
1 min read•By Research Desk
About Ajanta Pharma
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such... as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India. Read more
-
Incorporated
1979
-
Chairman
Mannalal B Agrawal
-
Managing Director
Yogesh M Agrawal
-
Group
Vimal Agrawal
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Ajanta Pharma Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsParticipation In Investor Conference
19-May-2026Disclosure As Per Regulation 30 Of SEBI (LODR)
05-May-2026Intimation Of Grant And Cancellation Of Options
05-May-2026Exchange Intimation Pursuant To Reg 30
22-Apr-2026No News & Announcements are available.
FAQs for Ajanta Pharma
What is the current share price of Ajanta Pharma Ltd Today?
The share price of Ajanta Pharma Ltd is ₹3,248.20 (NSE) and ₹3,245.40 (BSE) as of 19-May-2026 IST. Ajanta Pharma Ltd has given a return of 36.66% in the last 3 years.
What is the current PB & PE ratio of Ajanta Pharma Ltd?
The P/E ratio of Ajanta Pharma Ltd is 38.60 times as on 19-May-2026, a 15 premium to its peers’ median range of 33.65 times.
The P/B ratio of Ajanta Pharma Ltd is 9.00 times as on 19-May-2026, a 96 premium to its peers’ median range of 4.59 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
35.53
|
8.64
|
|
2024
|
34.52
|
7.91
|
|
2023
|
25.89
|
4.49
|
|
2022
|
14.45
|
4.73
|
|
2021
|
15.82
|
5.18
|
What is the 52 Week High and Low of Ajanta Pharma Ltd?
The 52-week high and low of Ajanta Pharma Ltd are Rs 3,314.90 and Rs 2,329.90 as of 19-May-2026.
What is the market cap of Ajanta Pharma Ltd?
Ajanta Pharma Ltd has a market capitalisation of ₹ 40,762 Cr as on 19-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Ajanta Pharma Ltd?
Before investing in Ajanta Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.